Variant report

Variant	esv3421459
Chromosome Location	chr9:100614656-100617704
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:181)
CpG islands
(count:551)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:181 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:100614820-100615239	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr9:100616407-100616413	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr9:100616331-100616473	Hela-S3	cervix:	n/a	n/a
4	CHD2	chr9:100616044-100616681	Hela-S3	cervix:	n/a	n/a
5	CHD2	chr9:100616408-100616611	H1-hESC	embryonic stem cell:	n/a	n/a
6	CREB1	chr9:100616132-100616744	A549	lung:	n/a	n/a
7	CTBP2	chr9:100613864-100616060	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr9:100616289-100618535	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr9:100615960-100616110	BJ	skin:	n/a	n/a
10	CTCF	chr9:100616320-100616470	Hela-S3	cervix:	n/a	n/a
11	CTCF	chr9:100616320-100616470	HMF	breast:	n/a	n/a
12	CTCF	chr9:100616300-100616450	HRPEpiC	eye:	n/a	n/a
13	CTCF	chr9:100616282-100616458	GM19238	blood:	n/a	n/a
14	CTCF	chr9:100616300-100616450	GM12866	blood:	n/a	n/a
15	CTCF	chr9:100616260-100616410	GM12866	blood:	n/a	n/a
16	CTCF	chr9:100616233-100616476	Fibrobl	skin:	n/a	n/a
17	CTCF	chr9:100616320-100616470	SAEC	small airway:	n/a	n/a
18	CTCF	chr9:100616260-100616410	GM12868	blood:	n/a	n/a
19	CTCF	chr9:100616300-100616450	GM12864	blood:	n/a	n/a
20	CTCF	chr9:100615541-100616886	A549	lung:	n/a	n/a
21	CTCF	chr9:100616520-100616670	RPTEC	kidney:	n/a	n/a
22	CTCF	chr9:100616218-100616451	A549	lung:	n/a	n/a
23	CTCF	chr9:100615880-100616030	SK-N-SH_RA	brain:	n/a	n/a
24	CTCF	chr9:100616300-100616450	AG04449	skin:	n/a	n/a
25	CTCF	chr9:100616316-100616372	GM10266	blood:	n/a	n/a
26	CTCF	chr9:100616238-100616507	A549	lung:	n/a	n/a
27	CTCF	chr9:100616300-100616450	SAEC	small airway:	n/a	n/a
28	CTCF	chr9:100616280-100616430	HFF-Myc	foreskin:	n/a	n/a
29	CTCF	chr9:100616260-100616410	GM12873	blood:	n/a	n/a
30	CTCF	chr9:100616300-100616450	A549	lung:	n/a	n/a
31	CTCF	chr9:100616270-100616462	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr9:100616340-100616490	Hela-S3	cervix:	n/a	n/a
33	CTCF	chr9:100616300-100616450	HCFaa	heart:	n/a	n/a
34	CTCF	chr9:100616307-100616452	GM12878	blood:	n/a	n/a
35	CTCF	chr9:100617080-100617230	SK-N-SH_RA	brain:	n/a	n/a
36	CTCF	chr9:100616262-100616410	GM10248	blood:	n/a	n/a
37	CTCF	chr9:100616320-100616470	HRE	kidney:	n/a	n/a
38	CTCF	chr9:100616240-100616390	WI-38	lung:	n/a	n/a
39	CTCF	chr9:100616232-100616486	ProgFib	skin:	n/a	n/a
40	CTCF	chr9:100616300-100616450	AG04450	lung:	n/a	n/a
41	CTCF	chr9:100616237-100616479	GM12891	blood:	n/a	n/a
42	CTCF	chr9:100616285-100616461	GM19239	blood:	n/a	n/a
43	CTCF	chr9:100616340-100616490	GM12864	blood:	n/a	n/a
44	CTCF	chr9:100616300-100616450	HUVEC	blood vessel:	n/a	n/a
45	CTCF	chr9:100616320-100616470	GM12870	blood:	n/a	n/a
46	CTCF	chr9:100616280-100616430	GM12867	blood:	n/a	n/a
47	CTCF	chr9:100616320-100616470	GM12873	blood:	n/a	n/a
48	CTCF	chr9:100616320-100616470	GM12871	blood:	n/a	n/a
49	CTCF	chr9:100616320-100616470	BJ	skin:	n/a	n/a
50	CTCF	chr9:100616231-100616460	IMR90	lung:	n/a	n/a

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:100615084-100615134	HL-60	blood:	n/a
2	chr9:100616469-100616519	HL-60	blood:	n/a
3	chr9:100615084-100615134	HL-60	blood:	n/a
4	chr9:100616469-100616519	HL-60	blood:	n/a
5	chr9:100615201-100615251	NH-A	brain:	n/a
6	chr9:100616469-100616519	RPTEC	kidney:	n/a
7	chr9:100615796-100615846	HEK293	kidney:	embryo
8	chr9:100615201-100615251	AG09319	gingival:	n/a
9	chr9:100617370-100617420	GM12878	blood:	n/a
10	chr9:100616607-100616657	HCT-116	colon:	n/a
11	chr9:100615201-100615251	SK-N-SH	brain:	n/a
12	chr9:100615796-100615846	AoSMC	blood vessel:	n/a
13	chr9:100615357-100615407	CMK	blood:	n/a
14	chr9:100616469-100616519	CMK	blood:	n/a
15	chr9:100617370-100617420	HCT-116	colon:	n/a
16	chr9:100615796-100615846	PANC-1	pancreas:	n/a
17	chr9:100615244-100615294	NHBE	bronchial:	n/a
18	chr9:100614879-100614929	A549	lung:	n/a
19	chr9:100616469-100616519	HUVEC	blood vessel:	n/a
20	chr9:100614879-100614929	MCF-7	breast:	n/a
21	chr9:100615357-100615407	MCF-7	breast:	n/a
22	chr9:100615084-100615134	HRE	kidney:	n/a
23	chr9:100617370-100617420	GM12891	blood:	n/a
24	chr9:100615084-100615134	GM19239	blood:	n/a
25	chr9:100616469-100616519	HCT-116	colon:	n/a
26	chr9:100615201-100615251	PrEC	prostate:	n/a
27	chr9:100615084-100615134	HRPEpiC	eye:	n/a
28	chr9:100615796-100615846	IMR90	lung:	fetal
29	chr9:100616469-100616519	HRCEpiC	kidney:	n/a
30	chr9:100617370-100617420	ECC-1	luminal epithelium:	n/a
31	chr9:100615244-100615294	NB4	blood:	n/a
32	chr9:100615201-100615251	AoSMC	blood vessel:	n/a
33	chr9:100615084-100615134	SK-N-SH	brain:	n/a
34	chr9:100615357-100615407	ProgFib	skin:	n/a
35	chr9:100615201-100615251	PFSK-1	brain:	n/a
36	chr9:100615244-100615294	MCF10A-Er-Src	breast:	n/a
37	chr9:100616469-100616519	AoSMC	blood vessel:	n/a
38	chr9:100615357-100615407	H1-hESC	embryonic stem cell:	embryo
39	chr9:100616607-100616657	AG04449	skin:	fetal
40	chr9:100615796-100615846	HCM	heart:	n/a
41	chr9:100615084-100615134	HCPEpiC	choroid plexus:	n/a
42	chr9:100617370-100617420	SKMC	muscle:	n/a
43	chr9:100615357-100615407	SKMC	muscle:	n/a
44	chr9:100615796-100615846	SK-N-MC	brain:	n/a
45	chr9:100615244-100615294	HNPCEpiC	eye:	n/a
46	chr9:100616469-100616519	U87	brain:	n/a
47	chr9:100615357-100615407	AG09309	skin:	n/a
48	chr9:100615201-100615251	PANC-1	pancreas:	n/a
49	chr9:100617370-100617420	Caco-2	colon:	n/a
50	chr9:100615796-100615846	HNPCEpiC	eye:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:100616472..100617973-chr9:100620292..100623040,2	K562	blood:
2	chr9:100614821..100616567-chr9:100616970..100619601,2	MCF-7	breast:
3	chr9:100617184..100619335-chr9:100637041..100639858,3	MCF-7	breast:

No data

Variant related genes	Relation type
FOXE1	TF binding region
FOXE1	CpG island
ENSG00000178919	chromatin interactions

Extended variants
information (count: 119 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:119 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146835176	chr9:100614667-100614668	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs139625186	chr9:100614697-100614698	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs35423363	chr9:100614710-100614711	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs377396378	chr9:100614814-100614815	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs577311703	chr9:100614907-100614908	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs190685546	chr9:100614938-100614939	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs553469661	chr9:100614943-100614944	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs573516154	chr9:100614964-100614965	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs145242614	chr9:100614969-100614970	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs112208273	chr9:100614982-100614983	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs181889250	chr9:100614993-100614994	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs72753509	chr9:100615000-100615001	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs544810041	chr9:100615022-100615023	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs138209404	chr9:100615049-100615050	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs907577	chr9:100615117-100615118	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs3758246	chr9:100615122-100615123	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs186577916	chr9:100615132-100615133	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs202083084	chr9:100615168-100615169	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs149147279	chr9:100615201-100615202	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs527655082	chr9:100615312-100615313	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs549008482	chr9:100615330-100615331	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs907576	chr9:100615359-100615360	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs537691208	chr9:100615370-100615371	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs34253329	chr9:100615398-100615399	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs549565118	chr9:100615402-100615403	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs571040106	chr9:100615415-100615416	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs538339695	chr9:100615416-100615417	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs553796558	chr9:100615420-100615421	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs571969135	chr9:100615433-100615434	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs536198571	chr9:100615517-100615518	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs190685791	chr9:100615524-100615525	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs143226042	chr9:100615552-100615553	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs13302470	chr9:100615553-100615554	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs544848416	chr9:100615564-100615565	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs376060243	chr9:100615614-100615615	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs553582440	chr9:100615627-100615628	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs7849497	chr9:100615660-100615661	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs545190501	chr9:100615688-100615689	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs182980986	chr9:100615744-100615745	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs370502386	chr9:100615796-100615797	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs527693580	chr9:100615869-100615870	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs1867277	chr9:100615914-100615915	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs1867278	chr9:100615949-100615950	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs531484350	chr9:100616018-100616019	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs549601899	chr9:100616020-100616021	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs1867279	chr9:100616041-100616042	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs1867280	chr9:100616066-100616067	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs547180177	chr9:100616078-100616079	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs565757553	chr9:100616117-100616118	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs187644329	chr9:100616283-100616284	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
overgrowth syndrome	16570072	CNVD
Neurodevelopmental disorder	22521361	CNVD
Nicotine dependence	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:381 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:100613400-100615400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
2	chr9:100613400-100615600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
3	chr9:100613400-100615600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
4	chr9:100613400-100615600	Bivalent Enhancer	Spleen	Spleen
5	chr9:100613400-100618800	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
7	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
8	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
9	chr9:100613600-100615200	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
10	chr9:100613600-100618000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
11	chr9:100613800-100614800	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr9:100613800-100615200	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
13	chr9:100613800-100615400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
14	chr9:100613800-100615600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
15	chr9:100613800-100615600	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
16	chr9:100613800-100615800	Bivalent Enhancer	Fetal Intestine Large	intestine
17	chr9:100613800-100616200	Bivalent Enhancer	Liver	Liver
18	chr9:100613800-100616400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
19	chr9:100613800-100616400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr9:100613800-100616400	Bivalent Enhancer	Fetal Muscle Leg	muscle
21	chr9:100613800-100616400	Bivalent Enhancer	Fetal Stomach	stomach
22	chr9:100613800-100616600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr9:100613800-100616800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
24	chr9:100613800-100617400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
25	chr9:100613800-100617800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
26	chr9:100614000-100614800	Bivalent Enhancer	Right Ventricle	heart
27	chr9:100614000-100615000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
28	chr9:100614000-100615000	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
29	chr9:100614000-100615000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr9:100614000-100615400	Enhancers	Pancreas	Pancrea
31	chr9:100614000-100615600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr9:100614000-100615600	Bivalent Enhancer	Adipose Nuclei	Adipose
33	chr9:100614000-100615600	Bivalent Enhancer	Brain Cingulate Gyrus	brain
34	chr9:100614000-100615800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr9:100614000-100616400	Bivalent Enhancer	Lung	lung
36	chr9:100614000-100616600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
37	chr9:100614000-100617800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
38	chr9:100614000-100617800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr9:100614200-100614800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
40	chr9:100614200-100615000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
41	chr9:100614200-100615400	Weak transcription	Gastric	stomach
42	chr9:100614200-100615600	Bivalent/Poised TSS	Esophagus	oesophagus
43	chr9:100614400-100614800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr9:100614400-100614800	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr9:100614400-100614800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr9:100614400-100614800	Bivalent Enhancer	Brain Hippocampus Middle	brain
47	chr9:100614400-100615000	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
48	chr9:100614400-100615000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr9:100614400-100615000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr9:100614400-100615000	Flanking Bivalent TSS/Enh	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links